olmesartan medoxomil

Olmesartan medoxomil is a prodrug ester derivative of olmesartan, featuring a methyl ester linkage at the proline moiety and a tetrazole ring critical for angiotensin II receptor antagonism. Its structure incorporates a 4'-biphenyl carboxylic acid group and a substituted proline scaffold, which undergo metabolic hydrolysis to yield the active parent drug. The compound serves as a direct precursor in the synthetic pathway of olmesartan, with the ester functionality enhancing oral bioavailability. This impurity is utilized as an HPLC reference standard for quantifying residual prodrug in olmesartan formulations.